Differences in brain pathological changes between rotenone and 6-hydroxydopamine Parkinson's disease models

Neural Regeneration Research
Lan-Xiang LiuJuan Du

Abstract

Rotenone and 6-hydroxydopamine are two drugs commonly used to generate Parkinson's disease animal models. They not only achieve degenerative changes of dopaminergic neurons in the substantia nigra, but also satisfy the requirements for iron deposition. However, few studies have compared the characteristics of these two models by magnetic resonance imaging. In this study, rat models of Parkinson's disease were generated by injection of 3 μg rotenone or 10 μg 6-hydroxydopamine into the right substantia nigra. At 1, 2, 4, and 6 weeks after injection, coronal whole-brain T2-weighted imaging, transverse whole-brain T2-weighted imaging, and coronal diffusion tensor weighted imaging were conducted to measure fractional anisotropy and T2* values at the injury site. The fractional anisotropy value on the right side of the substantia nigra was remarkably lower at 6 weeks than at other time points in the rotenone group. In the 6-hydroxydopamine group, the fractional anisotropy value was decreased, but T2* values were increased on the right side of the substantia nigra at 1 week. Our findings confirm that the 6-hydroxydopamine-induced model is suitable for studying dopaminergic neurons over short periods, while the rotenone-induced model m...Continue Reading

References

Sep 16, 2003·Neuron·William Dauer, Serge Przedborski
Feb 10, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Nicolas LapointeFrancesca Cicchetti
Oct 27, 2004·Cell and Tissue Research·Andreas Schober
Mar 1, 2005·Magnetic Resonance Imaging·E Mark HaackeAndre Obenaus
Sep 24, 2005·The European Journal of Neuroscience·P M CarveyZ D Ling
Jan 4, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Jordi BovéSerge Przedborski
Jun 7, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·H Diana RosasDavid H Salat
Dec 21, 2006·Topics in Magnetic Resonance Imaging : TMRI·Steven D BrassRohit Bakshi
Nov 30, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Patrick L McGeer, Edith G McGeer
May 13, 2008·Journal of Neurology, Neurosurgery, and Psychiatry·R CaslakeC Counsell
Dec 29, 2012·American Journal of Alzheimer's Disease and Other Dementias·Bingmei DengJun Wang
Mar 8, 2014·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Eva Alonso-OrtizG Bruce Pike
Jun 5, 2015·Fiziolohichnyĭ zhurnal·L P Voitenko, A G Nikonenko
Mar 10, 2017·International Journal of Molecular Sciences·Ramón Cacabelos

❮ Previous
Next ❯

Citations

Jan 31, 2020·Journal of Chemical Neuroanatomy·Sachchida Nand Rai, Payal Singh

❮ Previous
Next ❯

Software Mentioned

SPSS
MAGNETOM

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.